日本新薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2018/07/02 | 6,840 | 6,960 | 6,570 | 6,600 | -280 | -4.1% | 1,004,700 |
2018/06/29 | 6,780 | 6,930 | 6,510 | 6,880 | +80 | +1.2% | 746,100 |
2018/06/28 | 6,660 | 6,920 | 6,600 | 6,800 | +390 | +6.1% | 1,121,700 |
2018/06/27 | 6,350 | 6,530 | 6,340 | 6,410 | +80 | +1.3% | 318,200 |
2018/06/26 | 6,300 | 6,370 | 6,270 | 6,330 | -30 | -0.5% | 333,400 |
2018/06/25 | 6,540 | 6,550 | 6,300 | 6,360 | -100 | -1.5% | 243,600 |
2018/06/22 | 6,420 | 6,540 | 6,400 | 6,460 | -10 | -0.2% | 278,000 |
2018/06/21 | 6,570 | 6,730 | 6,430 | 6,470 | ±0 | ±0% | 360,800 |
2018/06/20 | 6,210 | 6,610 | 6,160 | 6,470 | -440 | -6.4% | 1,164,900 |
2018/06/19 | 7,160 | 7,170 | 6,810 | 6,910 | -400 | -5.5% | 415,300 |
2018/06/18 | 7,550 | 7,560 | 7,240 | 7,310 | -220 | -2.9% | 256,600 |
2018/06/15 | 7,690 | 7,700 | 7,520 | 7,530 | -110 | -1.4% | 305,100 |
2018/06/14 | 7,570 | 7,670 | 7,520 | 7,640 | +30 | +0.4% | 206,000 |
2018/06/13 | 7,570 | 7,690 | 7,500 | 7,610 | +110 | +1.5% | 202,000 |
2018/06/12 | 7,490 | 7,580 | 7,430 | 7,500 | +10 | +0.1% | 209,300 |
2018/06/11 | 7,470 | 7,560 | 7,440 | 7,490 | +30 | +0.4% | 150,400 |
2018/06/08 | 7,470 | 7,510 | 7,410 | 7,460 | -150 | -2% | 301,700 |
2018/06/07 | 7,660 | 7,700 | 7,550 | 7,610 | -50 | -0.7% | 161,300 |
2018/06/06 | 7,730 | 7,750 | 7,630 | 7,660 | -110 | -1.4% | 178,400 |
2018/06/05 | 7,890 | 7,950 | 7,700 | 7,770 | -230 | -2.9% | 145,900 |
2018/06/04 | 7,870 | 8,020 | 7,810 | 8,000 | +280 | +3.6% | 230,300 |
2018/06/01 | 7,790 | 7,850 | 7,690 | 7,720 | -90 | -1.2% | 164,200 |
2018/05/31 | 7,600 | 7,870 | 7,530 | 7,810 | +210 | +2.8% | 399,100 |
2018/05/30 | 7,650 | 7,680 | 7,550 | 7,600 | -150 | -1.9% | 187,500 |
2018/05/29 | 7,740 | 7,890 | 7,680 | 7,750 | -60 | -0.8% | 151,000 |
2018/05/28 | 7,730 | 7,920 | 7,730 | 7,810 | +20 | +0.3% | 133,500 |
2018/05/25 | 7,790 | 7,840 | 7,760 | 7,790 | -20 | -0.3% | 158,700 |
2018/05/24 | 7,880 | 7,890 | 7,780 | 7,810 | -80 | -1% | 189,000 |
2018/05/23 | 7,880 | 7,950 | 7,810 | 7,890 | +10 | +0.1% | 180,600 |
2018/05/22 | 7,800 | 7,920 | 7,790 | 7,880 | +100 | +1.3% | 229,000 |
2018/05/21 | 7,890 | 7,900 | 7,740 | 7,780 | -150 | -1.9% | 131,000 |
2018/05/18 | 7,880 | 7,970 | 7,800 | 7,930 | +60 | +0.8% | 167,200 |
2018/05/17 | 7,760 | 7,900 | 7,740 | 7,870 | +200 | +2.6% | 225,300 |
2018/05/16 | 7,780 | 7,910 | 7,630 | 7,670 | -100 | -1.3% | 285,600 |
2018/05/15 | 7,990 | 8,090 | 7,750 | 7,770 | -120 | -1.5% | 337,600 |
2018/05/14 | 8,190 | 8,220 | 7,850 | 7,890 | -390 | -4.7% | 271,700 |
2018/05/11 | 7,940 | 8,360 | 7,940 | 8,280 | +450 | +5.7% | 490,600 |
2018/05/10 | 7,560 | 7,880 | 7,410 | 7,830 | +120 | +1.6% | 579,700 |
2018/05/09 | 7,670 | 7,730 | 7,600 | 7,710 | +50 | +0.7% | 276,800 |
2018/05/08 | 7,770 | 7,870 | 7,630 | 7,660 | -140 | -1.8% | 258,000 |
2018/05/07 | 7,840 | 7,930 | 7,690 | 7,800 | +20 | +0.3% | 216,200 |
2018/05/02 | 7,710 | 7,820 | 7,560 | 7,780 | +50 | +0.6% | 418,500 |
2018/05/01 | 8,060 | 8,060 | 7,670 | 7,730 | -430 | -5.3% | 412,600 |
2018/04/27 | 7,990 | 8,170 | 7,920 | 8,160 | +320 | +4.1% | 320,500 |
2018/04/26 | 7,790 | 7,870 | 7,760 | 7,840 | -190 | -2.4% | 370,300 |
2018/04/25 | 7,880 | 8,050 | 7,870 | 8,030 | +180 | +2.3% | 374,600 |
2018/04/24 | 8,240 | 8,260 | 7,810 | 7,850 | -390 | -4.7% | 498,000 |
2018/04/23 | 8,340 | 8,350 | 8,090 | 8,240 | -240 | -2.8% | 287,100 |
2018/04/20 | 8,090 | 8,490 | 8,080 | 8,480 | +390 | +4.8% | 600,000 |
2018/04/19 | 8,040 | 8,250 | 7,970 | 8,090 | +280 | +3.6% | 548,000 |
1701~
1750
件表示中 / 3725件
類似銘柄と比較する
現在ご覧いただいている「日本新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
日本新薬 | 340,000円 | +8.0% | -15.3% | 3.65% | 9.55倍 | 0.93倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
久光薬 | 412,500円 | +5.8% | +1.2% | 2.91% | 13.68倍 | 1.09倍 |
|
貼る鎮痛消炎剤首位。医療用シェア5割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
ツムラ | 334,900円 | +3.8% | -19.9% | 4.06% | 10.88倍 | 0.83倍 |
|
医療用漢方薬で国内シェア8割超。高齢者、がん支持療法、女性関連の3領域を重点に市場深耕 |
サワイGHD | 186,400円 | +5.9% | +684.6% | 2.95% | 12.37倍 | 1.24倍 |
|
ジェネリック(後発)薬大手メーカー。21年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
ペプチド | 163,300円 | +5.0% | +1.5% | 0.00% | 13.97倍 | 3.72倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
市場注目の銘柄
チャート関連のコラム